Option Care Health, Inc. (NASDAQ:OPCH) Stock Has Average Price Target of $29.92

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have been given a consensus rating of “Hold” by the sixteen research firms that are presently covering the firm, MarketBeat reports. Fourteen investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $29.17.

A number of equities analysts have recently weighed in on OPCH shares. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and upped their target price for the company from $28.00 to $32.05 in a report on Tuesday, October 6th. William Blair lowered shares of Option Care Health from an “outperform” rating to a “market perform” rating in a research report on Tuesday, October 6th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $24.00 price target (down from $26.00) on shares of Option Care Health in a report on Thursday, July 30th. Stephens reaffirmed an “equal weight” rating and set a $24.00 price objective (down from $30.00) on shares of Option Care Health in a research report on Friday, July 17th. Finally, Wall Street Zen raised shares of Option Care Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 1st.

Key Headlines Impacting Option Care Health

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: The proposed CD&R and McKesson buyout provides a clear cash value of $32.05 per share and represents a substantial premium to Option Care Health’s pre-deal trading levels. Option Care Health agrees to $32.05 buyout by CD&R and McKesson
• Positive Sentiment: One analysis argues that Option Care Health may still be undervalued despite the $5.8 billion transaction, supporting the view that the offer could be attractive relative to the company’s underlying business value. Option Care Health stock may be undervalued despite the $5.8 billion buyout
• Neutral Sentiment: JPMorgan reaffirmed a “Neutral” rating, indicating limited expected upside beyond the announced offer price and a focus on deal completion rather than ongoing operating growth. JPMorgan reaffirms neutral rating
• Neutral Sentiment: Analyst price-target coverage remains relevant mainly for gauging the spread to the $32.05 cash consideration, as the pending acquisition limits the importance of standalone valuation targets. Option Care Health analyst price targets
• Negative Sentiment: Several firms have reduced their ratings: Citizens JMP moved to “Hold,” Barrington Research downgraded the stock to “Market Perform,” and Truist cut its rating from “Strong Buy” to “Hold.” The downgrades signal reduced upside after the buyout announcement. Citizens JMP lowers rating to hold Barrington Research downgrade
• Negative Sentiment: Kahn Swick & Foti is investigating whether the $32.05 consideration and sale process were adequate. Such scrutiny could create legal or timing uncertainty, although the investigation does not itself indicate that the transaction will fail. Investor alert regarding the proposed sale

Institutional Investors Weigh In On Option Care Health

Institutional investors have recently modified their holdings of the stock. Andina Capital Management LLC grew its holdings in shares of Option Care Health by 2.6% during the 4th quarter. Andina Capital Management LLC now owns 16,320 shares of the company’s stock valued at $520,000 after acquiring an additional 419 shares in the last quarter. Pacer Advisors Inc. raised its holdings in shares of Option Care Health by 1.3% during the first quarter. Pacer Advisors Inc. now owns 42,649 shares of the company’s stock worth $1,148,000 after acquiring an additional 528 shares in the last quarter. Central Pacific Bank Trust Division raised its holdings in shares of Option Care Health by 3.9% during the third quarter. Central Pacific Bank Trust Division now owns 14,369 shares of the company’s stock worth $323,000 after acquiring an additional 540 shares in the last quarter. State of Michigan Retirement System raised its holdings in shares of Option Care Health by 1.6% during the first quarter. State of Michigan Retirement System now owns 38,159 shares of the company’s stock worth $1,027,000 after acquiring an additional 600 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund raised its holdings in shares of Option Care Health by 2.5% during the first quarter. Oregon Public Employees Retirement Fund now owns 32,530 shares of the company’s stock worth $876,000 after acquiring an additional 800 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Stock Performance

Shares of OPCH stock opened at $31.07 on Monday. The company has a market capitalization of $4.65 billion, a price-to-earnings ratio of 23.36, a P/E/G ratio of 1.89 and a beta of 0.58. Option Care Health has a 1-year low of $18.01 and a 1-year high of $36.80. The company has a current ratio of 1.47, a quick ratio of 0.98 and a debt-to-equity ratio of 0.91. The stock’s fifty day simple moving average is $24.25 and its 200-day simple moving average is $23.60.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.02. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%. The firm had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.42 billion. During the same period in the prior year, the business earned $0.41 EPS. The business’s revenue for the quarter was up 1.9% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. On average, sell-side analysts predict that Option Care Health will post 1.70 earnings per share for the current fiscal year.

About Option Care Health

Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.